The rapid advancement of artificial intelligence (AI) holds transformative potential for an equitable global health. However, AI also present challenges such as algorithmic bias and privacy concerns that can exacerbate social inequities if not carefully managed. The MI4EGH Symposium aims to broaden the dialogue on harnessing AI for equity in global health.
MI4EGH will focus on AI-powered epidemic prediction and management, including global challenges such as pandemic prediction and prevention, and how AI has been used to forecast outbreaks and optimize resource allocation during health crises. We will also focus on healthcare accessibility, highlighting innovations in telemedicine and mobile health technologies that bring medical services to underserved areas, with a special emphasis on AI-driven diagnostic tools designed for remote and resource-limited settings.
MI4EGH will focus on AI fairness for healthcare, tackling algorithm biases. We will explore strategies for ethical AI design and implementation to ensure equitable healthcare outcomes across diverse populations. We also examine the use of AI in mental health, where AI's potential in diagnosing and treating mental health conditions, including the use of AI-driven chatbots for support and predictive analytics for early detection, will be examined.
Furthermore, we will discuss the protection of health data in AI applications, focusing on laws, patient consent, and frameworks for secure data sharing. Enhancing the training of healthcare professionals through AI will also be a key topic, particularly the use of virtual simulations and personalized learning in developing countries.
Lastly, the symposium will examine the development of global regulatory and policy frameworks necessary for governing the ethical use of AI in healthcare. This includes ensuring safety, effectiveness, and equitable access. The event will feature presentations from leading researchers addressing these critical issues, followed by panel discussions exploring potential solutions to significant challenges such as data limitations and accessibility. We aim to foster a collaborative environment where policymakers, researchers, and practitioners can share insights and drive progress towards equitable global health outcomes through machine intelligence.
The MI4EGH will include (but not limited to) the following topics:
AI in Epidemic Prediction and Management: Discuss the use of AI in forecasting outbreaks, optimizing resource allocation during epidemics, and managing public health responses. This could include case studies on AI's role in the COVID-19 pandemic.
Healthcare Accessibility and Remote Diagnostics: Explore innovations in telemedicine and mobile health technologies that use AI to provide medical services in underserved areas. Emphasize AI-driven diagnostic tools that can be used in remote or resource-limited settings.
Fairness in AI Health Systems: Address the challenges of bias in AI algorithms that can lead to disparities in healthcare quality. This session could include discussions on the ethical design and implementation of AI systems to ensure fairness across diverse populations.
AI in Mental Health: Focus on the use of AI for diagnosing and treating mental health issues, with an emphasis on scalable solutions that can reach global populations. This might include chatbots for mental health support, predictive analytics for early diagnosis of mental health conditions, and AI-driven personal wellness tools.
Health Data Privacy and Security: Tackle the critical issues surrounding the privacy and security of health data in AI applications. This could involve discussions on data protection laws, patient consent, and secure data sharing frameworks.
AI-Enhanced Medical Training and Education: Discuss how AI and machine learning can be used to train healthcare professionals, particularly in developing countries. This could include virtual simulations, personalized learning, and AI tutors for medical education.
Regulatory and Policy Frameworks on AI and Healthcare: Discuss the development of global regulatory and policy frameworks to govern the use of AI in healthcare, which is essential for ensuring safety, effectiveness, and equitable access.
Invited talks, paper presentations, poster sessions, panel discussions, and spotlight talks of accepted posters.
Professor, Yale School of Public Health
Professor, Virginia Tech, Computer Science Department
Research Scientist, NIST
Associate Program Director, National Science Foundation, U.S.A.
Senior Investigator, NIH/NLM. Deputy Director for Literature Search, National Center for Biotechnology Information (NCBI)
Professor of Bioethics,
Tuskegee University Bioethics Center
Raj Reddy Associate Professor of Machine Learning, Carnegie Mellon University
Chief Technology & Science Officer, Abridge
John E. Savage Assistant Professor of Computer Science and Data Science, Brown University
Professor & Associate Dean for AI Innovation, George Mason University
Professor, Congressional Science & Technology Fellow in AI, University of Tennessee Knoxville
Distinguished Professor, Institute of Statistics, National Yang Ming Chiao Tung University, Taiwan
Head of Technological Innovation, Aderas
Dr. Hong Qin
Old Dominion Univesity
University of Tennessee at Chattanooga
Dr. Jude Dzevela Kong
York University
Dr. Letu Qingge
North Carolina A&T State University
Dr. Frank Liu
Old Dominion University